INS and metabolic dysfunction-associated steatohepatitis: This fatty acid excess in body districts other than adipose tissue can also impair insulin action or cause non-alcoholic fatty liver disease (NAFLD), meaning a spectrum of liver tissue changes ranging from steatosis to non-alcoholic steatohepatitis (NASH), cirrhosis, and eventually, possibly leading to hepatocellular carcinoma [32].